Jiaxiong Tan1, Shaohua Chen1, Yuhong Lu1, Danlin Yao1, Ling Xu1, Yikai Zhang1, Lijian Yang1, Jie Chen1, Jing Lai1, Zhi Yu1, Kanger Zhu1, Yangqiu Li1,2,3. 1. Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China. 2. Department of Hematology, the First Affiliated Hospital, Jinan University, Guangzhou 510632, China. 3. Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou 510632, China.
Abstract
OBJECTIVE: To investigate the association between the T cell inhibitory receptor programmed death 1 (PD-1) and T cell exhaustion status in T cells from patients with de novo acute myeloid leukemia (AML) and AML in complete remission (CR). METHODS: Surface expression of PD-1 and the exhaustion and immunosenescence markers CD244 and CD57 on CD3+, CD4+ and CD8+ T cells from peripheral blood samples from 20 newly diagnosed, untreated AML patients and 10 cases with AML in CR was analyzed by flow cytometry. Twenty-three healthy individuals served as control. RESULTS: A significantly higher percentage of PD-1+ cells were found for CD3+ T cells in the de novo AML group compared with healthy controls. In addition, an increased level of PD-1+CD8+ T cells, but not PD-1+CD4+, was found for CD3+ T cells in the de novo AML and AML-CR samples. A higher percentage of CD244+CD4+, CD244+CD8+, CD57+CD4+ and CD57+CD8+ T cells was found in CD3+ T cells in samples from those with de novo AML compared with those from healthy controls. Strong increased PD-1+CD244+ and PD-1+CD57+ co-expression was found for CD4+ and CD8+ T cells in the de novo AML group compared with healthy controls. CONCLUSIONS: We characterized the major T cell defects, including co-expression of PD-1 and CD244, CD57-exhausted T cells in patients with de novo AML, and found a particular influence on CD8+ T cells, suggesting a poor anti-leukemia immune response in these patients.
OBJECTIVE: To investigate the association between the T cell inhibitory receptor programmed death 1 (PD-1) and T cell exhaustion status in T cells from patients with de novo acute myeloid leukemia (AML) and AML in complete remission (CR). METHODS: Surface expression of PD-1 and the exhaustion and immunosenescence markers CD244 and CD57 on CD3+, CD4+ and CD8+ T cells from peripheral blood samples from 20 newly diagnosed, untreated AML patients and 10 cases with AML in CR was analyzed by flow cytometry. Twenty-three healthy individuals served as control. RESULTS: A significantly higher percentage of PD-1+ cells were found for CD3+ T cells in the de novo AML group compared with healthy controls. In addition, an increased level of PD-1+CD8+ T cells, but not PD-1+CD4+, was found for CD3+ T cells in the de novo AML and AML-CR samples. A higher percentage of CD244+CD4+, CD244+CD8+, CD57+CD4+ and CD57+CD8+ T cells was found in CD3+ T cells in samples from those with de novo AML compared with those from healthy controls. Strong increased PD-1+CD244+ and PD-1+CD57+ co-expression was found for CD4+ and CD8+ T cells in the de novo AML group compared with healthy controls. CONCLUSIONS: We characterized the major T cell defects, including co-expression of PD-1 and CD244, CD57-exhausted T cells in patients with de novo AML, and found a particular influence on CD8+ T cells, suggesting a poor anti-leukemia immune response in these patients.
Entities:
Keywords:
Acute myeloid leukemia; PD-1; T cell exhaustion
Authors: D Serrano; J Monteiro; S L Allen; J Kolitz; P Schulman; S M Lichtman; A Buchbinder; V P Vinciguerra; N Chiorazzi; P K Gregersen Journal: J Immunol Date: 1997-02-01 Impact factor: 5.422
Authors: L E Van den Hove; P Vandenberghe; S W Van Gool; J L Ceuppens; H Demuynck; G E Verhoef; M A Boogaerts Journal: Leuk Res Date: 1998-02 Impact factor: 3.156
Authors: C Krupka; P Kufer; R Kischel; G Zugmaier; F S Lichtenegger; T Köhnke; B Vick; I Jeremias; K H Metzeler; T Altmann; S Schneider; M Fiegl; K Spiekermann; P A Bauerle; W Hiddemann; G Riethmüller; M Subklewe Journal: Leukemia Date: 2015-08-04 Impact factor: 11.528
Authors: Lei Qin; Donye Dominguez; Siqi Chen; Jie Fan; Alan Long; Minghui Zhang; Deyu Fang; Yi Zhang; Timothy M Kuzel; Bin Zhang Journal: Oncotarget Date: 2016-09-20
Authors: Adam J Lamble; Yoko Kosaka; Ted Laderas; Allie Maffit; Andy Kaempf; Lauren K Brady; Weiwei Wang; Nicola Long; Jennifer N Saultz; Motomi Mori; David Soong; Clare V LeFave; Fei Huang; Homer Adams; Marc M Loriaux; Cristina E Tognon; Pierrette Lo; Jeffrey W Tyner; Guang Fan; Shannon K McWeeney; Brian J Druker; Evan F Lind Journal: Proc Natl Acad Sci U S A Date: 2020-06-08 Impact factor: 11.205